Literature DB >> 22580830

Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica.

Rebecca S Romero1, Ismael Gutierrez, Eugene Wang, Anthony T Reder, M Tariq Bhatti, Jacqueline T Bernard, Adil Javed.   

Abstract

A 42-year-old African American woman with a 5-year history of neuromyelitis optica was found to have an incongruous homonymous hemianopia. Optical coherence tomography (OCT) showed corresponding left homonymous hemimacular thinning. Magnetic resonance imaging of the brain demonstrated a demyelinating lesion in the left optic tract (OT) just anterior to the lateral geniculate nucleus and diffusion tensor magnetic resonance tractography confirmed axonal fiber loss in the left OT. This case illustrates the complementary and confirmatory roles of visual field testing, macular OCT, and neuroimaging in an OT lesion, which caused selective hemimacular thinning through retrograde degeneration.

Entities:  

Mesh:

Year:  2012        PMID: 22580830     DOI: 10.1097/WNO.0b013e3182504688

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  4 in total

1.  Retrograde degeneration of visual pathway: hemimacular thinning of retinal ganglion cell layer in progressive and active multiple sclerosis.

Authors:  Yu-Min Huang-Link; Abbas Al-Hawasi; Inger Eveman
Journal:  J Neurol       Date:  2014-10-14       Impact factor: 4.849

2.  Optic neuritis in neuromyelitis optica.

Authors:  Marc H Levin; Jeffrey L Bennett; A S Verkman
Journal:  Prog Retin Eye Res       Date:  2013-03-30       Impact factor: 21.198

3.  Early macular ganglion cell-inner plexiform layer analysis in non-arteritic anterior ischemic optic neuropathy.

Authors:  Sang Woo Park; Yong Sok Ji; Hwan Heo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-03       Impact factor: 3.117

Review 4.  Homonymous hemianopia: challenges and solutions.

Authors:  Denise Goodwin
Journal:  Clin Ophthalmol       Date:  2014-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.